Correlation Between Tcr2 Therapeutics and Stoke Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Stoke Therapeutics, you can compare the effects of market volatilities on Tcr2 Therapeutics and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Stoke Therapeutics.
Diversification Opportunities for Tcr2 Therapeutics and Stoke Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tcr2 and Stoke is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Stoke Therapeutics go up and down completely randomly.
Pair Corralation between Tcr2 Therapeutics and Stoke Therapeutics
Given the investment horizon of 90 days Tcr2 Therapeutics is expected to generate 1.08 times less return on investment than Stoke Therapeutics. But when comparing it to its historical volatility, Tcr2 Therapeutics is 1.15 times less risky than Stoke Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Stoke Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 707.00 in Stoke Therapeutics on August 28, 2024 and sell it today you would earn a total of 471.00 from holding Stoke Therapeutics or generate 66.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 24.65% |
| Values | Daily Returns |
Tcr2 Therapeutics vs. Stoke Therapeutics
Performance |
| Timeline |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Stoke Therapeutics |
Tcr2 Therapeutics and Stoke Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tcr2 Therapeutics and Stoke Therapeutics
The main advantage of trading using opposite Tcr2 Therapeutics and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |